Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
LISCure Biosciences Inc. logo — Live Biotherapeutics Immunotherapeutic Drugs

LISCure Biosciences Inc.

Live Biotherapeutics Immunotherapeutic Drugs

Founded 2018 Korea South Korea South 6 employees Series B Total: $17.50B Biotechnology, Health Care

General Information

Company Name LISCure Biosciences Inc.
Founded Year 2018
Location Korea South Korea South +3
Employees 6
Industries Biotechnology, Health Care
Funding Stage Series B
Social

Get notified when LISCure Biosciences Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About LISCure Biosciences Inc.

LISCure Biosciences is a biotechnology and healthcare startup founded in 2018. The company recently secured a noteworthy KRW12.50B Series B investment at 31 December 2020. The investment consortium included the participation of Industrial Bank of Korea, Korea Investment & Securities, Muirwoods Ventures, Hana Financial Investment, TINVESTMENT, Valuesystem, Hi Investment & Securities, LabGenomics, iNtRON Biotechnology, and eBEST. This substantial investment signifies confidence in LISCure's innovative bio-technological solutions and augurs well for the future of the company. Despite the lack of specific headquarters information, this recent funding round highlights the potential for significant growth and impact within the biotechnology and healthcare industries.

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 10
Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		31 Dec 2020
Seed Round •••••• - 25 Jul 2019

LISCure Biosciences Inc. Alternatives & Competitors

LISCure Biosciences Inc. vs
STORM Therapeutics Limited
STORM Therapeutics Limited United Kingdom

Harnessing the power of RNA modification

Series C
16 employees
Biotechnology, Health Care
LISCure Biosciences Inc. vs
Servatus Ltd
Servatus Ltd Australia

Developing novel microbiome-based treatments for autoimmune diseases, including rheumatoid arthritis...

24 employees

FAQ About LISCure Biosciences Inc.

Live Biotherapeutics Immunotherapeutic Drugs
LISCure Biosciences Inc. was founded in 2018.
LISCure Biosciences Inc. is headquartered in Korea South.
LISCure Biosciences Inc. operates in the following industries: Biotechnology, Health Care.
LISCure Biosciences Inc. has approximately 6 employees.
LISCure Biosciences Inc. has completed 2 funding rounds, raising a total of $17.50B. The latest funding stage is Series B.
Top alternatives and competitors to LISCure Biosciences Inc. include STORM Therapeutics Limited, Servatus Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
LISCure Biosciences Inc. and STORM Therapeutics Limited are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors LISCure Biosciences Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy